Measles-containing-vaccine second-dose (MCV2) immunization coverage in Luxembourg
Luxembourg: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 94.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Luxembourg, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Luxembourg is 94.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 9.3% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Luxembourg peaked at 94.0% in 2023 and was at its lowest, 0.0%, in 2000.
Luxembourg ranks 43rd of 194 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 69.6% | 0.0% | 90.0% | 10 |
| 2020s | 92.3% | 90.0% | 94.0% | 6 |
Countries ranked near Luxembourg
- 43 Sweden 94.0% compare
- 43 Kyrgyzstan 94.0% compare
- 43 Ukraine 94.0% compare
- 43 China (People’s Republic of) 94.0% compare
- 43 Denmark 94.0% compare
More health data for Luxembourg
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5867 % change on previous year (2090)
- Heat deaths vs projected death rates 1,220 (2090)
- Un projection of annual infant deaths 4 (2100)
- Population ages 65 and above, total, annual growth rate 3.67 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.1581 units per person (2025)
- Population, female, annual growth rate 1.43 % change on previous year (2025)
- Population, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population, female, per capita 0.4965 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Luxembourg?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Luxembourg was 94.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Luxembourg?
- The highest recorded value was 94.0% in 2023.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Luxembourg?
- The lowest recorded value was 0.0% in 2000.
- How does Luxembourg rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Luxembourg ranks 43rd out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Luxembourg?
- Over the last ten years it is up 9.3%. The long-run trend across the full record is volatile.
- Where does this Luxembourg data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).